Comparison of Intense Pulsed Light Therapy on Patients with Meibomian Gland Dysfunction Using AQUA CEL and M22 Devices

The purpose of this study was to compare the efficacy of Intense Pulsed Light (IPL) therapy for meibomian gland dysfunction (MGD) using the new AQUA CEL (AC, Jeisys) device and the traditional M22 (Lumenis) device. A total of 59 eyes of 59 patients with MGD (12 men and 47 women, mean age 49 ± 12 yea...

Full description

Bibliographic Details
Main Authors: Shima Fukuoka, Reiko Arita
Format: Article
Language:English
Published: MDPI AG 2022-07-01
Series:Journal of Clinical Medicine
Subjects:
Online Access:https://www.mdpi.com/2077-0383/11/15/4265
_version_ 1797441680903766016
author Shima Fukuoka
Reiko Arita
author_facet Shima Fukuoka
Reiko Arita
author_sort Shima Fukuoka
collection DOAJ
description The purpose of this study was to compare the efficacy of Intense Pulsed Light (IPL) therapy for meibomian gland dysfunction (MGD) using the new AQUA CEL (AC, Jeisys) device and the traditional M22 (Lumenis) device. A total of 59 eyes of 59 patients with MGD (12 men and 47 women, mean age 49 ± 12 years) were enrolled. They randomly received four sessions of IPL therapy every three weeks either with AC (30 eyes) or M22 (29 eyes). Standard Patient Evaluation of Eye Dryness (SPEED) questionnaire score, noninvasive breakup time (NIBUT), lid margin abnormalities, corneal and conjunctival fluorescein staining, fluorescein breakup time (FBUT), Schirmer’s test, meiboscore and meibum grade were evaluated before treatment and one month after treatment. Before IPL, no significant differences were seen in age, gender, or measured parameters between the AC and M22 groups (<i>p</i> > 0.05, respectively). SPEED score, NIBUT, lid margin abnormalities, fluorescein staining, FBUT, and meibum grade improved significantly in both groups after IPL compared to before IPL (<i>p</i> < 0.001, respectively). There were no significant differences in measured parameters between the two groups after IPL (<i>p</i> > 0.05, respectively). IPL therapy with AC and M22 devices has been shown to be equally effective for the treatment of MGD.
first_indexed 2024-03-09T12:28:40Z
format Article
id doaj.art-5e9a08bb13f1463f8c99fc15f482ea59
institution Directory Open Access Journal
issn 2077-0383
language English
last_indexed 2024-03-09T12:28:40Z
publishDate 2022-07-01
publisher MDPI AG
record_format Article
series Journal of Clinical Medicine
spelling doaj.art-5e9a08bb13f1463f8c99fc15f482ea592023-11-30T22:31:40ZengMDPI AGJournal of Clinical Medicine2077-03832022-07-011115426510.3390/jcm11154265Comparison of Intense Pulsed Light Therapy on Patients with Meibomian Gland Dysfunction Using AQUA CEL and M22 DevicesShima Fukuoka0Reiko Arita1Lid and Meibomian Gland Working Group (LIME), 626-11 Minami-Nakano, Minumaku, Saitama 337-0042, JapanLid and Meibomian Gland Working Group (LIME), 626-11 Minami-Nakano, Minumaku, Saitama 337-0042, JapanThe purpose of this study was to compare the efficacy of Intense Pulsed Light (IPL) therapy for meibomian gland dysfunction (MGD) using the new AQUA CEL (AC, Jeisys) device and the traditional M22 (Lumenis) device. A total of 59 eyes of 59 patients with MGD (12 men and 47 women, mean age 49 ± 12 years) were enrolled. They randomly received four sessions of IPL therapy every three weeks either with AC (30 eyes) or M22 (29 eyes). Standard Patient Evaluation of Eye Dryness (SPEED) questionnaire score, noninvasive breakup time (NIBUT), lid margin abnormalities, corneal and conjunctival fluorescein staining, fluorescein breakup time (FBUT), Schirmer’s test, meiboscore and meibum grade were evaluated before treatment and one month after treatment. Before IPL, no significant differences were seen in age, gender, or measured parameters between the AC and M22 groups (<i>p</i> > 0.05, respectively). SPEED score, NIBUT, lid margin abnormalities, fluorescein staining, FBUT, and meibum grade improved significantly in both groups after IPL compared to before IPL (<i>p</i> < 0.001, respectively). There were no significant differences in measured parameters between the two groups after IPL (<i>p</i> > 0.05, respectively). IPL therapy with AC and M22 devices has been shown to be equally effective for the treatment of MGD.https://www.mdpi.com/2077-0383/11/15/4265intense pulsed lighttreatmentmeibomian gland dysfunctiondry eye diseasemeibomian gland expression
spellingShingle Shima Fukuoka
Reiko Arita
Comparison of Intense Pulsed Light Therapy on Patients with Meibomian Gland Dysfunction Using AQUA CEL and M22 Devices
Journal of Clinical Medicine
intense pulsed light
treatment
meibomian gland dysfunction
dry eye disease
meibomian gland expression
title Comparison of Intense Pulsed Light Therapy on Patients with Meibomian Gland Dysfunction Using AQUA CEL and M22 Devices
title_full Comparison of Intense Pulsed Light Therapy on Patients with Meibomian Gland Dysfunction Using AQUA CEL and M22 Devices
title_fullStr Comparison of Intense Pulsed Light Therapy on Patients with Meibomian Gland Dysfunction Using AQUA CEL and M22 Devices
title_full_unstemmed Comparison of Intense Pulsed Light Therapy on Patients with Meibomian Gland Dysfunction Using AQUA CEL and M22 Devices
title_short Comparison of Intense Pulsed Light Therapy on Patients with Meibomian Gland Dysfunction Using AQUA CEL and M22 Devices
title_sort comparison of intense pulsed light therapy on patients with meibomian gland dysfunction using aqua cel and m22 devices
topic intense pulsed light
treatment
meibomian gland dysfunction
dry eye disease
meibomian gland expression
url https://www.mdpi.com/2077-0383/11/15/4265
work_keys_str_mv AT shimafukuoka comparisonofintensepulsedlighttherapyonpatientswithmeibomianglanddysfunctionusingaquacelandm22devices
AT reikoarita comparisonofintensepulsedlighttherapyonpatientswithmeibomianglanddysfunctionusingaquacelandm22devices